ANIXA BIOSCIENCES, INC. Common Stock, Value, Issued
ANIXA BIOSCIENCES, INC. (ANIX) had Common Stock, Value, Issued of $346.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-09-09
- 2026-07-31: Common Stock, Value, Issued $346.00K.
- 2026-04-30: Common Stock, Value, Issued $339.00K.
- 2026-01-31: Common Stock, Value, Issued $335.00K.
- 2025-10-31: Common Stock, Value, Issued $330.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-07-31 | $346.00K 10-Q · filed 2026-09-09 | |
| 2026-04-30 | $339.00K 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $335.00K 10-Q · filed 2026-03-09 | |
| 2025-10-31 | $330.00K 10-Q · filed 2026-09-09 | |
| 2025-07-31 | $328.00K 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $322.00K 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $322.00K 10-Q · filed 2025-03-11 | |
| 2024-10-31 | $322.00K 10-K · filed 2026-01-12 | |
| 2024-07-31 | $321.00K 10-Q · filed 2024-09-06 | |
| 2024-04-30 | $320.00K 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $318.00K 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $311.00K 10-K · filed 2025-01-10 | |
| 2023-07-31 | $310.00K 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $310.00K 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $309.00K 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $309.00K 10-K · filed 2024-01-16 | |
| 2022-07-31 | $307.00K 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $302.00K 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $301.00K 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $301.00K 10-K · filed 2023-01-04 | $300.51K 10-K · filed 2022-01-04 |
| 2021-07-31 | $299.50K 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $314.50K 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $261.79K 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $242.49K 10-K · filed 2022-01-04 | |
| 2020-07-31 | $236.54K 10-Q · filed 2020-09-08 | |
| 2020-04-30 | $214.79K 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $208.41K 10-Q · filed 2020-03-09 | |
| 2019-10-31 | $203.32K 10-K · filed 2021-01-07 | |
| 2019-07-31 | $201.63K 10-Q · filed 2019-09-06 | |
| 2019-04-30 | $200.05K 10-Q · filed 2019-06-12 | |
| 2019-01-31 | $194.70K 10-Q · filed 2019-03-13 | |
| 2018-10-31 | $189.09K 10-K · filed 2020-01-09 | |
| 2018-07-31 | $186.96K 10-Q · filed 2018-09-07 | |
| 2018-04-30 | $168.50K 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $166.31K 10-Q · filed 2018-03-09 | |
| 2017-10-31 | $166.03K 10-K · filed 2019-01-11 | |
| 2017-07-31 | $151.20K 10-Q · filed 2017-09-08 | |
| 2017-04-30 | $116.95K 10-Q · filed 2017-05-26 | |
| 2017-01-31 | $87.58K 10-Q · filed 2017-03-16 | |
| 2016-10-31 | $87.52K 10-K · filed 2018-01-09 | |
| 2016-07-31 | $87.48K 10-Q · filed 2016-08-19 | |
| 2016-04-30 | $87.40K 10-Q · filed 2016-05-20 | |
| 2016-01-31 | $87.31K 10-Q · filed 2016-02-19 | |
| 2015-10-31 | $87.25K 10-K · filed 2016-12-08 | |
| 2015-07-31 | $87.21K 10-Q · filed 2015-08-18 | |
| 2015-04-30 | $2.19M 10-Q · filed 2015-05-22 | |
| 2015-01-31 | $2.20M 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $87.88K 10-K · filed 2015-12-23 | $2.20M 10-K · filed 2015-01-29 |
| 2014-07-31 | $2.37M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $2.19M 10-Q · filed 2014-06-16 | |
| 2014-01-31 | $2.11M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $2.09M 10-K · filed 2015-01-29 | |
| 2013-07-31 | $2.06M 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | $2.00M 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $1.85M 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | $1.85M 10-K/A · filed 2014-01-17 | |
| 2012-07-31 | $1.84M 10-Q · filed 2012-09-14 | |
| 2012-04-30 | $1.81M 10-Q · filed 2012-06-14 | |
| 2012-01-31 | $1.80M 10-Q · filed 2012-03-16 | |
| 2011-10-31 | $1.76M 10-K · filed 2013-01-29 | |
| 2011-07-31 | $1.72M 10-Q/A · filed 2011-10-14 | |
| 2010-10-31 | $1.54M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |